Short description
Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Description
Checkpoint Therapeutics mainly engages in advancing the development of cancer immunotherapy and targeted oncology treatments. It is dedicated to developing and bringing cancer therapies to market faster and actively pursuing product purchases, in-licensing, and co-development opportunities that align with its areas of expertise. The company provides a streamlined approach that lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors, and providers benefit from effective and affordable treatment options.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Waltham, Massachusetts, United States, North America
Founded on
January 1, 2014
Exited on
December 20, 2016
Went public on
December 20, 2016
Stock symbol
CKPT
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access